Randomized Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab With or Without Concurrent Avastin for Previously Untreated B-Chronic Lymphocytic Leukemia (CLL).

Trial Profile

Randomized Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab With or Without Concurrent Avastin for Previously Untreated B-Chronic Lymphocytic Leukemia (CLL).

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jun 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Cyclophosphamide; Pegfilgrastim; Pentostatin; Rituximab
  • Indications Chronic lymphocytic leukaemia; Lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 May 2017 Status changed from active, no longer recruiting to completed.
    • 20 Apr 2016 Results (n=62) presented at the 107th Annual Meeting of the American Association for Cancer Research
    • 04 Feb 2016 Planned End Date changed from 1 Sep 2015 to 1 May 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top